Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys.

European journal of nuclear medicine and molecular imaging·2022
Same author

Author Correction: Novel multimodal molecular imaging of Vitamin H (Biotin) transporter activity in the murine placenta.

Scientific reports·2021
Same author

Novel multimodal molecular imaging of Vitamin H (Biotin) transporter activity in the murine placenta.

Scientific reports·2020
Same author

Radiolabeled Cationic Peptides for Targeted Imaging of Infection.

Contrast media & molecular imaging·2020
Same author

Imaging of HER2 with [<sup>89</sup>Zr]pertuzumab in Response to T-DM1 Therapy.

Cancer biotherapy & radiopharmaceuticals·2019
Same author

Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2018

Related Experiment Video

Updated: Jun 8, 2026

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

Chemically modified antibodies as diagnostic imaging agents.

Jeffrey J Day1, Bernadette V Marquez, Heather E Beck

  • 1Chemistry Department, University of California, Davis, CA 95616, USA.

Current Opinion in Chemical Biology
|October 19, 2010
PubMed
Summary

New antibody imaging techniques engineer proteins for enhanced molecular recognition and targeted delivery. These methods improve upon traditional antibody imaging by using unlabeled engineered proteins and novel probe capture strategies for better signal generation.

More Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Related Experiment Videos

Last Updated: Jun 8, 2026

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Area of Science:

  • Biotechnology
  • Molecular Imaging
  • Protein Engineering

Background:

  • Traditional antibody imaging involves administering labeled antibodies, which can be limited by target and metabolism visualization.
  • Genetically engineered proteins derived from antibodies offer improved molecular recognition properties for imaging applications.

Purpose of the Study:

  • To explore novel applications of engineered antibodies for advanced molecular imaging.
  • To develop improved strategies for targeted imaging beyond conventional labeled antibody administration.

Main Methods:

  • Genetically engineering antibody-derived proteins to enhance molecular recognition properties.
  • Developing protocols for molecular targeting using unlabeled engineered proteins.
  • Implementing novel probe capture strategies, including irreversible binding and enzyme active sites.

Main Results:

  • Engineered proteins demonstrate enhanced molecular recognition, improving imaging utility.
  • New strategies enable targeted imaging with unlabeled proteins followed by probe capture.
  • Novel probe capture systems generate signals upon binding or uptake, enhancing detection.

Conclusions:

  • Engineered antibody-derived proteins represent a significant advancement in molecular imaging.
  • These novel approaches offer improved specificity and signal generation compared to traditional methods.
  • Future developments in probe capture and protein engineering will further enhance diagnostic imaging capabilities.